MELD score is a better prognostic model than Child-Turcotte-Pugh score or Discriminant Function score in patients with alcoholic hepatitis

被引:211
作者
Srikureja, W
Kyulo, NL
Runyon, BA
Hu, KQ
机构
[1] Univ Calif Irvine, Div Gastroenterol, Orange, CA 92668 USA
[2] Univ So Calif, Liver Unit, Rancho Los Amigos Med Ctr, Downey, CA USA
[3] Loma Linda Univ, Ctr Med, Div Gastroenterol, Loma Linda, CA USA
关键词
alcoholic hepatitis; MELD score; retrospective study; mortality; sensitivity; specificity;
D O I
10.1016/j.jhep.2004.12.022
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background/Aims: The aim of the present study was to compare MELD score, Child-Turcotte-Pugh (CTP) score, modified Maddrey's Discriminant Function (DF) score, and the related variables in predicting in-hospital mortality of patients with alcoholic hepatitis. Methods: A retrospective chart review and statistical analyses were done on 202 patients consecutively admitted for alcoholic hepatitis from 1997 to 2002 at the Liver Unit at Rancho Los Amigos Medical Center. Results: Twenty-nine patients died during the hospitalization. Admission MELD score (OR 1.1, P = 0.005), first week MELD score (OR 1.2, P < 0.0001), and first week increase in MELD score (OR 1.3, P < 0.0001) were independently associated with in-hospital mortality. The area under the receiver operating curve (AUC) for the first week increase in MELD score was higher compared to CTP score (P=0.0004) and DF score (P=0.059). Moreover, the first week MELD score >= 20 had the best sensitivity (91 %) and specificity (85 %) compared with admission or first week change MELD score. Conclusions: The present study indicates that in patients with alcoholic hepatitis, admission, first week, and first week change in MELD score are significantly independent predictors for in-hospital mortality. MELD score is a more valuable model than CTP or DF score in patients admitted with alcoholic hepatitis. (c) 2005 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:700 / 706
页数:7
相关论文
共 15 条
[1]   Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: A double-blind, placebo-controlled trial [J].
Akriviadis, E ;
Botla, R ;
Briggs, W ;
Han, S ;
Reynolds, T ;
Shakil, O .
GASTROENTEROLOGY, 2000, 119 (06) :1637-1648
[2]  
Arroyo V, 1996, HEPATOLOGY, V23, P164, DOI 10.1002/hep.510230122
[3]  
CHEDID A, 1991, AM J GASTROENTEROL, V86, P210
[4]   DO CORTICOSTEROIDS REDUCE MORTALITY FROM ALCOHOLIC HEPATITIS - A METAANALYSIS OF THE RANDOMIZED TRIALS [J].
IMPERIALE, TF ;
MCCULLOUGH, AJ .
ANNALS OF INTERNAL MEDICINE, 1990, 113 (04) :299-307
[5]   A model to predict survival in patients with end-stage liver disease [J].
Kamath, PS ;
Wiesner, RH ;
Malinchoc, M ;
Kremers, W ;
Therneau, TM ;
Kosberg, CL ;
D'Amico, G ;
Dickson, ER ;
Kim, WR .
HEPATOLOGY, 2001, 33 (02) :464-470
[6]  
Kumashiro R, 1996, ALCOHOL CLIN EXP RES, V20, pA383, DOI 10.1111/j.1530-0277.1996.tb01813.x
[7]  
Maddrey W C, 2000, Clin Liver Dis, V4, P115, DOI 10.1016/S1089-3261(05)70099-4
[8]  
MADDREY WC, 1978, GASTROENTEROLOGY, V75, P193
[9]   Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis (AH): individual data analysis of the last three randomized placebo controlled double blind trials of corticosteroids in severe AH [J].
Mathurin, P ;
Mendenhall, CL ;
Carithers, RL ;
Ramond, MJ ;
Maddrey, WC ;
Garstide, P ;
Rueff, B ;
Naveau, S ;
Chaput, JC ;
Poynard, T .
JOURNAL OF HEPATOLOGY, 2002, 36 (04) :480-487
[10]   Pathogenesis, diagnosis, and treatment of alcoholic liver disease [J].
Menon, KVN ;
Gores, GJ ;
Shah, VH .
MAYO CLINIC PROCEEDINGS, 2001, 76 (10) :1021-1029